Vekemans Johan, Ballou W Ripley
GlaxoSmithKline Biologicals, Emerging Diseases, Global Clinical Research and Development Vaccines, Rixensart, Belgium.
Expert Rev Vaccines. 2008 Mar;7(2):223-40. doi: 10.1586/14760584.7.2.223.
The development and implementation of a malaria vaccine would constitute a major breakthrough for global health. Recently, numerous new candidates have entered clinical testing, following strategies that are as diverse as the malaria cycle is complex. While promising results have been obtained, some candidate vaccines have not fulfilled expectations. The challenges are not merely scientific; further progresses will require the development of competent investigator networks, partnerships between academics, industry and funding agencies, and continuous political commitment. In this review, we present the developmental status of all malaria vaccine candidates that are currently in human clinical testing against Plasmodium falciparum, as well as selected malaria vaccine candidates at preclinical development stage, and discuss the main challenges facing the field of malaria vaccine development.
疟疾疫苗的研发与应用将成为全球卫生领域的一项重大突破。近来,众多新的候选疫苗进入了临床试验阶段,其研发策略如同疟疾周期一样复杂多样。尽管已取得了一些有前景的成果,但部分候选疫苗并未达到预期效果。这些挑战不仅仅是科学性的;进一步的进展将需要建立有能力的研究人员网络、学术界、产业界和资助机构之间的合作关系,以及持续的政治承诺。在本综述中,我们介绍了目前正在针对恶性疟原虫进行人体临床试验的所有疟疾候选疫苗的研发状况,以及处于临床前研发阶段的部分疟疾候选疫苗,并讨论了疟疾疫苗研发领域面临的主要挑战。